All Posts by
The College of Medicine recognizes several department of pediatric staff members as recipients of a 2024 Exemplary Teacher Award. This award recognizes up to 10% of the College of Medicine faculty nominated by their department Chair and selected based on their teaching excellence of medical students, residents…
Recent Events 10th Annual Pediatric Medical Student Research Forum The Department of Pediatrics sponsored the 10th Annual Pediatrics Medical Student Research Forum on August 31, 2024, at Disney’s Yacht Club Resort in Orlando. This was a national stage, with over 50 students from coast to coast representing over 11 states,…
After decades of research, gene therapy is starting to work. Shannon Boye is a professor of cellular and molecular therapeutics at the University of Florida. She is also the co-founder and chief scientific officer of Atsena Therapeutics. Shannon’s problem is this: How do you use gene therapy to…
Five specialties at the University of Florida Health Shands Children’s Hospital were ranked among the best in the nation today (Oct. 8) in the latest U.S. News & World Report survey of pediatric hospitals across the United States.
UF Health Shands Children’s Hospital is looking forward to meeting you at the 2024 AAP National Conference & Exhibition experience in Orlando, Florida! We invite you to learn how the University of Florida Department of Pediatrics and University of Florida Health Shands Children’s Hospital are serving as perennial leaders in…
After the treatment, one patient saw her first star. Another saw snowflakes for the first time. Other patients were newly able to navigate outside of the home or to read the labels on their child’s Halloween candy.
Whitney Moss, office manager for the Division of Pediatric Allergy, Immunology, and Rheumatology, plays a key role in the coordination and care of young patients.
Elias Sayour, M.D., discusses the challenges of creating therapeutic cancer vaccines, advantages for mRNA vaccines and how to adapt mRNA to treat patients with cancer.
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a pediatric cancer for which treatment has gone unchanged for 50 years, a new University of Florida Health-led study shows.
University of Florida researchers have received approval from the Food and Drug Administration to test two new experimental therapies in first-ever human clinical trials for a subtype of medulloblastoma, the most common pediatric malignant brain tumor.
